NASDAQ:SYRE
Spyre Therapeutics, Inc. Stock Insider Trading
$37.80
+0 (+0%)
At Close: May 17, 2024
| Date | Action | Amount | Person | Type |
|---|---|---|---|---|
| May 14, 2024 | Buy | 11 323 | Fairmount Funds Management Llc | Stock Option (Right to Buy) |
| May 14, 2024 | Buy | 21 980 | Milligan Sandra | Stock Option (Right to Buy) |
| May 14, 2024 | Buy | 11 323 | Albers Jeffrey W. | Stock Option (Right to Buy) |
| May 14, 2024 | Buy | 11 323 | Stelzer Laurie | Stock Option (Right to Buy) |
| May 14, 2024 | Buy | 11 323 | Henderson Michael Thomas | Stock Option (Right to Buy) |
| May 14, 2024 | Buy | 0 | Milligan Sandra | |
| Apr 25, 2024 | Buy | 3 639 680 | Fairmount Funds Management Llc | Common Stock |
| Apr 25, 2024 | Sell | 90 992 | Fairmount Funds Management Llc | Series A Preferred Stock |
| Feb 15, 2024 | Buy | 400 | Turtle Cameron | Common Stock |
| Feb 01, 2024 | Buy | 40 000 | Mckenna Mark C. | Stock Option (Right to Buy) |
| Feb 01, 2024 | Buy | 477 000 | Mckenna Mark C. | Stock Option (Right to Buy) |
| Feb 01, 2024 | Buy | 277 750 | Turtle Cameron | Stock Option (Right to Buy) |
| Feb 01, 2024 | Buy | 70 000 | Burrows Scott L | Stock Option (Right to Buy) |
| Feb 01, 2024 | Buy | 63 000 | King-jones Heidy | Stock Option (Right to Buy) |
| Dec 29, 2023 | Buy | 406 038 | Fairmount Funds Management Llc | Common Stock |
| Dec 29, 2023 | Sell | 3 435 480 | Fairmount Funds Management Llc | Common Stock |
| Dec 07, 2023 | Buy | 16 667 | Fairmount Funds Management Llc | Series B Preferred Stock |
